K001344

Substantially Equivalent

ADVIA IMS

Applicant: Bayer Corp.
Product code: DIH
Advisory panel: Clinical Toxicology
Date received: 2000-04-27
Decision date: 2000-06-26
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Tarrytown, NY, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.